Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTPW) Long-Term Debt Issuances (2023)

Historic Long-Term Debt Issuances for 60 Degrees Pharmaceuticals (SXTPW) over the last 1 years, with Q2 2023 value amounting to $450000.0.

  • 60 Degrees Pharmaceuticals' Long-Term Debt Issuances changed N/A to $450000.0 in Q2 2023 from the same period last year, while for Dec 2023 it was $650000.0, marking a year-over-year change of. This contributed to the annual value of $650000.0 for FY2023, which is 1875.0% down from last year.
  • Per 60 Degrees Pharmaceuticals' latest filing, its Long-Term Debt Issuances stood at $450000.0 for Q2 2023.
  • 60 Degrees Pharmaceuticals' Long-Term Debt Issuances' 5-year high stood at $450000.0 during Q2 2023, with a 5-year trough of $200000.0 in Q1 2023.